Volume : VIII, Issue : IX, September - 2019

ADJUVANT CHEMOTHERAPY IN GASTRIC CANCER QUITO-ECUADOR

Ivonne Bravo Galarza, Christian Aguilar Erazo, Ana Calderon Cervantes, Mabel Sisalima Vazquez, Nelson Urbina Moreno, Priscila Yepez Guachamin, Alex Montes De Oca Gavilanez, Maria Herrera Herrera

Abstract :

OBJECTIVE: To determine the overall survival time in patients treated with adjuvant chemoradiotherapy. METHODS: Retrospective study of patients with a diagnosis of gastric adenocarcinoma or gastroesophageal junction who received adjuvant chemoradiotherapy treatment during the years 2011 to 2015. RESULTS: We analized 197 subjects of which 115 were men (58.4%) and 82 women (41.6%) were included in the analysis; between the ages of 18 and 89 years old, distributed in clinical stages IB to IIIC, showing a general average survival of 51.5 months with a Log Rank of 2.98; 95% CI (45.7 - 57.4) with a general survival of up to 90 months. CONCLUSION: The study showed a greater overall survival than the data reported in the Intergroup 0116 and ARTIST study.

Keywords :

Article: Download PDF    DOI : https://www.doi.org/10.36106/gjra  

Cite This Article:

ADJUVANT CHEMOTHERAPY IN GASTRIC CANCER QUITO-ECUADOR, Ivonne Bravo Galarza, Christian Aguilar Erazo, Ana Calderon Cervantes, Mabel Sisalima Vazquez, Nelson Urbina Moreno, Priscila Yepez Guachamin, Alex Montes de Oca Gavilanez, Maria Herrera Herrera GLOBAL JOURNAL FOR RESEARCH ANALYSIS : Volume-8 | Issue-9 | September-2019


Number of Downloads : 166


References :